Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Lactobacillus Reuteri (L. Reuteri) in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants Less Than 34 Weeks of Gestation

NCT04541771 is registered in ClinicalTrials.gov with Children's Hospital and Institute of Child Health, Multan as lead sponsor.

NCT NCT04541771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Lactobacillus Reuteri (L. Reuteri) in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants Less Than 34 Weeks of Gestation
Lead sponsor
Children's Hospital and Institute of Child Health, Multan
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2020
Completion date
January 31, 2021
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing enterocolitis, sepsis